Drugs / rAAV1 - (mi)RNA HTT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04885114 | Jul 2021 → Dec 2024 | Huntington disease | Voyager Therapeutics | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rAAV1 - (mi)RNA HTT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04885114 ↗ |
| Route | Other | “Single dose MRI guided intraparenchymal infusion of rAAV1 - (mi)RNA HTT.” NCT04885114 ↗ |